Media

Prof. Ronjon Nag at the IIT Bay Area Leadership Conference 2023.

Prof. Ronjon Nag on life extension, molecular aging research, and the path from today's average lifespans toward therapies that could push human healthspan well beyond 120 years.

Life expectancy rose fast. The ceiling near 120 still holds.

Takeaways
  • Average lifespans climbed from roughly 50 to 55 years to 76 for US men today, with countries like Japan and Norway pushing toward 100 or more. The oldest verified person reached 122; most researchers treat ~120 as the practical upper bound.
  • Competing theories explain aging: wear-and-tear (body parts that must be replaced), mitochondrial decline (energy production fading with age, with projects like Metrics Bio exploring regeneration), and the gains already captured through hygiene, refrigeration, and sanitation.
  • The next frontier may be an aging vaccine that stops or reverses the process, not just slows visible decline.
  • Escape velocity: extend life by roughly 20 years at a time as new therapies arrive, compounding until biological rejuvenation becomes self-sustaining.
  • Genetics explains an estimated 5 to 30 percent of lifespan (about 16 percent on average). Diet, social connection, exercise, sleep, and environment matter far more; Blue Zones show healthy communities routinely reach past 100.

Epigenetics, AI, and the long road to human trials.

Path forward
  • Epigenetic programming controls how identical DNA is read in each cell. Yamanaka factors (2012 Nobel Prize) can reset biological age using four proteins, with the goal of rejuvenating cells without erasing a person's identity or accumulated wisdom.
  • Most longevity approaches remain preclinical: cell cultures and animal models first. Human translation typically takes 15 to 20 years, costs roughly $1 billion per approved therapy, and succeeds only about 5 percent of the time.
  • AI is used to identify stronger candidates faster. Researchers are also testing whether approved drugs and supplements, recombined, can accelerate progress beyond starting from new chemistry.
  • Molecular life-extension research is still early, but epigenetics and AI-driven discovery offer a credible path to slowing or reversing biological aging. Broad, affordable therapies will take decades and major investment; escape velocity gives a framework for extending life step by step past 120.
Media
A vaccine for aging
Continue
Team
Prof. Ronjon Nag
Continue